KPC Pharmaceuticals,Inc. (600422.SS) announced a profit for full year that Dropped, from last year
The company's bottom line came in at RMB349.940 million, or RMB0.46 per share. This compares with RMB648.081 million, or RMB0.86 per share, last year.
The company's revenue for the period fell 21.7% to RMB6.575 billion from RMB8.401 billion last year.
KPC Pharmaceuticals,Inc. earnings at a glance (GAAP) :
-Earnings: RMB349.940 Mln. vs. RMB648.081 Mln. last year.-EPS: RMB0.46 vs. RMB0.86 last year.-Revenue: RMB6.575 Bln vs. RMB8.401 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.